Comparative study on microvascular occlusion and apoptosis in body and limb wounds in the horse

Wound Repair and Regeneration

Volumn 13, Issue 5, 2005, Pages 520-529

  Lepault, Élodie ^a   Céleste, Christophe ^a   Doré, Monique ^a   Martineau, Daniel ^a   Theoret, Christine L ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BANDAGE; BLOOD VESSEL OCCLUSION; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRON MICROSCOPY; EPITHELIZATION; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; FORELIMB; HISTOLOGY; HORSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIMB INJURY; MICROVASCULARIZATION; MICROVASCULATURE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKIN BIOPSY; VEIN DIAMETER; WOUND HEALING;

ANIMALS; APOPTOSIS; CICATRIX; EXTREMITIES; FEMALE; GRANULATION TISSUE; HORSES; MICROCIRCULATION; SKIN; THORACIC WALL; WOUND HEALING;

EID: 28944453517     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1067-1927.2005.00073.x     Document Type: Article

References (42)

1. Wilmink JM, van Herten J, van Weeren PR, Barneveld A. Retrospective study of primary intention healing and sequestrum formation in horses compared to ponies under clinical circumstances. Equine Vet J 2002;34:270-3.
2. Jacobs KA, Leach DH, Fretz PB, Townsend HGG. Comparative aspects of the healing of excisional wounds on the leg and body of horses. Vet Surg 1984;13:83-90.
3. Kischer CW. The microvessels in hypertrophic scars, keloids and related lesions: a review. J Submicrosc Cytol Pathol 1992;24:281-96.
4. Kischer CW, Shetlar MR. Microvasculature in hypertrophic scars and the effects of pressure. J Trauma 1979;19:757-64.
5. Wilmink JM, Van Weeren PR, Stolk PW, Van Mil FN, Barneveld A. Differences in second-intention wound healing between horses and ponies: histological aspects. Equine Vet J 1999;31:61-7.
6. 3 and basic fibroblast growth factor in full-thickness skin wounds of equine limbs and thorax. Vet Surg 2001;30:269-77.
7. Schwartz AJ, Wilson DA, Keegan KG, Ganjam VK, Sun Y, Weber KT, Zhang. J. Factors regulating collagen synthesis and degradation during second-intention healing of wounds in the thoracic region and the distal aspect of the forelimb of horses. Am J Vet Res 2002;63:1564-70.
8. Greenhalgh DG. The role of apoptosis in wound healing. Int J Biochem Cell Biol 1998;30:1019-30.
9. Desmoulière A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995;46:56-66.
10. Ladin DA, Hou Z, Patel D, McPhail M, Olson JC, Saed GM, Fivenson DP. p53 and apoptosis alterations in keloids and keloids fibroblasts. Wound Rep Reg 1998;6:28-37.
11. Sayah DN, Soo C, Shaw WW, Watson JW, Messadi D, Longaker MT, Zhang X, Ting K. Downregulation of apoptosis-related genes in keloid tissues. J Surg Res 1999;87:209-16.
12. Messadi DV, Le A, Berg S, Jewett A, Wen Z, Kelly P, Bertolami CN. Expression of apoptosis-associated genes by human dermal scar fibroblasts. Wound Rep Reg 1999;7:511-7.
13. Haupt S, Berger M, Goldberg Z, Haupt Y. Apoptosis - the p53 network. J Cell Sci 2003;116:4077-85.
14. King KL, Cidlowski JA. Cell cycle regulation and apoptosis. Annu Rev Physiol 1998;60:601-17.
15. Saed GM, Ladin D, Olson J, Han X, Hou Z, Fivenson D. Analysis of p53 gene mutations in keloids using PCR-based single-strand conformational polymorphism and DNA sequencing. Arch Dermatol 1998;134:963-7.
16. 3 and basic fibroblast growth factor in equine limb wounds healing normally or with proud flesh. Vet Surg 2002;31:266-77.
17. Barber SM. Second intention wound healing in the horse: the effect of bandages and topical corticosteroids. Proc Am Assoc Equine Pract 1989;35:107.
18. Theoret CL, Barber SM, Moyana TN, Townsend HGG, Archer J. Repair and function of synovium after arthroscopic synovectomy of the dorsal compartment of the equine antebrachiocarpal joint. Vet Surg 1996;25:142-53.
19. Smith JE, Mohandas N, Shohet SB. Variability in erythrocyte deformability among various mammals. Am Physio Soc 1979;236:H725-30.
20. 2 gradients. Microvasc Res 1976;12:259-74.
21. De Martin I, Theoret CL. Spatial and temporal expression of types I and II receptors for transforming growth factor β in normal equine skin and dermal wounds. Vet Surg 2004;33:70-6.
22. Martens A, De Moor A, Demeulemeester J, Ducatelle R. Histopathological characteristics of five clinical types of equine sarcoid. Res Vet Sci 2000;69:295-300.
23. Sporn MB, Roberts AB. Transforming growth factor-beta. Multiple actions and potential clinical applications. J Am Med Assoc 1989;262:938-41.
24. Wilmink JM, Stolk PW, van Weeren PR, Barneveld A. Differences hi second intention wound healing between horses and ponies: macroscopic aspects. Equine Vet J 1999;31:53-60.
25. Woolf AS, Bosch RJ, Fine LG. Growth factors in the pathogenesis of renovascular complications of diabetes mellitus. J Hypertens Suppl 1992;10:S11-6.
26. Berlanga J, Cibrian D, Guillen I, Freyre F, Alba JS, Lopez-Saura P, Merino N, Aldama A, Quintela A, Triana M, Montequin JF, Ajamieh H, Urquiza D, Ahmed N, Thornalley PJ. Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds. Clin Sci (London) 2005;109:83-95.
27. Van den boom R, Wilmink JM, O'Kane S, Wood J, Ferguson MWJ. Transforming growth factor-β levels during second-intention healing are related to the different course of wound contraction in horses and ponies. Wound Rep Reg 2002;10:188-94.
28. Canham PB, Potter RF, Woo D. Geometric accomodation between the dimensions of erythrocytes and the calibre of heart and muscle capillaries in the rat. J Physiol 1984;347:697-712.
29. Secomb TW, Hsu R. Motion of red blood cells in capillaries with variable cross-sections. J Biomech Eng 1996;118:538-44.
30. Hakkinen L, Westermarck J, Kahari VM, Larjava H. Human granulation tissue fibroblasts show enhanced proteoglycan gene expression and altered response to TGF-β1. J Dent Res 1996;75:1767-78.
31. Falanga V, Qian SW, Danielpour D, Katz MH, Roberts AB, Sporn MB. Hypoxia upregulates the synthesis of TGF-β1 by human dermal fibroblasts. J Invest Dermatol 1991;97:634-7.
32. Zhang HY, Phan SH. Inhibition of myofibroblast apoptosis by transforming growth factor b1. Am J Respir Cell Mol Biol 1999;21:658-65.
33. Ladin DA, Garner WL, Smith DJ. Excessive scarring as a consequence of healing. Wound Rep Reg 1995;3:6-14.
34. Sims DE. Diversity within pericytes. Clin Exp Pharmacol Physiol 2000;27:842-6.
35. Luo S, Benathan M, Raffoul W, Panizzon RG, Egloff DV. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 2001;107:87-96.
36. Blagosklonny MV. Loss of function and p53 protein stabilization. Oncogene 1997;15:1889-93.
37. Wang X, Rao SM, Yeldandi AV. Immunohistochemical analysis of p53 mutations in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma. Modem Pathol 1995;8:919-23.
38. Funayama E, Chodon T, Oyama A, Sugihara T. Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts: an important role in the pathogenesis of keloids. J Invest Dermatol 2003;121:1326-31.
39. Chopp M, Zhang Z, Freytag S. p53 expression in brain after middle cerebral artery occlusion in the rat. Biochem Biophys Res Commun 1992;182:1201-7.
40. Shimizu S, Eguchi Y, Kosaka H, Kamiike W, Matsuda H, Tsujimoto YL. Prevention of hypoxia-induced cell death by bcl-2 and bcl-xL. Nature 1995;374:811-3.
41. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 1995;21:1465-8.
42. Bozena B, Sticherling M. How specific is the TUNEL reaction? An account of a histochemical study on human skin. Am J Dermatopatho 2002;24:130-4.